COVID-19 Worsens Existing Liver Disease and Could Spur Liver Cancer Development!

Medical News: New research shows COVID-19 does more than just affect the lungs - it may also have serious effects on the liver, especially in individuals with pre-existing liver conditions. Researchers at the University of Campania in Italy found that the virus’s spike protein (specifically the S1 subunit) interacts with liver proteins, potentially worsening hepatitis B (HBV) and increasing the risk of liver cancer, known as hepatocellular carcinoma (HCC).


COVID-19 Worsens Existing Liver Disease and Could Spur Liver Cancer Development!

The study discovered that the S1 subunit of the SARS-CoV-2 spike protein binds to certain proteins in the liver, affecting key molecular pathways associated with HBV and HCC. This Medical News report dives deeper into the findings, exploring how COVID-19 could exacerbate liver conditions and possibly contribute to the onset of liver cancer.
 
The Study's Approach: Understanding the Spike Protein’s Role
The researchers used an “interactomic” analysis to investigate how SARS-CoV-2 interacts with human liver proteins. Interactomics studies how proteins interact within cells and how these interactions impact health. They focused on 12 specific human proteins that the S1 spike protein directly interacts with, causing changes in key metabolic and signaling pathways in liver cells. By tracing these interactions, scientists could predict how COVID-19 might worsen liver health and even promote cancer-related processes.
 
The team analyzed thousands of interactions between SARS-CoV-2 proteins and human proteins, relying on established protein databases such as BioGRID and STRING. Their findings show that COVID-19’s effects are highly complex, particularly because the virus’s proteins interact with numerous liver proteins simultaneously, sometimes leading to significant cellular stress and inflammation - key factors that could trigger or worsen liver disease.
 
Key Findings: How COVID-19 Could Lead to Cancer
COVID-19 has shown itself to be a powerful catalyst for various diseases, and liver conditions are no exception. The study found several crucial points:
 
-Activation of Cancer Pathways: COVID-19’s spike protein S1 not only exacerbates hepatitis B but may also promote processes related to liver cancer. Key genes linked to liver inflammation and cell survival were affected, such as TP53 and STAT3, both critical in managing inflammation and protecting cells from becoming cancerous.
 
-Overlapping Disease Pathways: Many of the molecular processes that SARS-CoV-2 activates in the liver overlap between hepatitis B and HCC. This overlap may explain why some COVID-19 patients experience worsened liver disease symptoms. The researchers found that 31 genes related to HCC are also active in HBV processes, showing a strong interconnection between these diseases in infected individuals.
 
-Potential for Long-Term Liver Dama ge: Even after recovery from COVID-19, individuals might still face liver issues. The S1 protein has been detected in the liver long after the virus clears from other organs. This persistence could maintain a state of low-level inflammation and cellular stress, setting the stage for chronic liver disease or even liver cancer in high-risk patients.
 
Why COVID-19’s Impact on the Liver Matters
The liver plays an essential role in filtering blood, managing nutrients, and detoxifying harmful substances. When viral proteins, such as the S1 spike protein, interact with liver proteins, it disrupts these vital functions. For instance, proteins involved in immune responses, cell survival, and inflammation can all become dysregulated, creating a highly stressed environment in liver cells.
 
Increased stress on liver cells could trigger cell death, particularly among cells already compromised by conditions like HBV. This raises the risk of liver fibrosis and cirrhosis, which are both precursors to liver cancer. Additionally, for people with metabolic disorders, such as fatty liver disease, COVID-19 could make these conditions much worse.
 
Could COVID-19 Lead to Liver Cancer in Healthy Individuals?
While liver damage is most concerning in patients with pre-existing conditions, the study raises questions about whether COVID-19 could potentially trigger liver cancer in otherwise healthy people. Although healthy livers may be more resilient, the SARS-CoV-2 S1 protein still interacts with pathways associated with cancer. For some, particularly those with genetic predispositions, this interaction could make them more susceptible to developing liver disease.
 
The study doesn’t confirm that everyone with COVID-19 will experience these outcomes, but it emphasizes the need for long-term liver monitoring, particularly in people who have had severe COVID-19 symptoms or those with liver conditions.
 
Managing COVID-19’s Liver Effects: Recommendations for Patients
To mitigate the potential risks posed by COVID-19, the researchers suggest several strategies for patients and healthcare providers:
 
-Close Monitoring for Liver Disease: Patients with HBV or a history of liver issues should undergo regular liver screenings. Blood tests for liver enzymes, imaging, and even biopsies may help identify early signs of liver damage or cancer development.
 
-Targeted Therapy for COVID-19 Patients: COVID-19 treatments should consider liver health. Antiviral drugs that target the SARS-CoV-2 S1 protein might reduce the risk of liver complications, although more research is necessary.
 
-Lifestyle Adjustments: Since liver health is influenced by lifestyle factors, patients recovering from COVID-19 are encouraged to limit alcohol, avoid excessive medication, and maintain a balanced diet to minimize liver strain.
 
Implications for Future Research
The potential link between COVID-19, liver disease, and cancer is just beginning to be explored. Future studies could focus on how different proteins of SARS-CoV-2, beyond the S1 spike, affect other organs. Additionally, understanding how individual genetic factors influence these interactions might help in identifying patients most at risk for liver complications.
 
Researchers are hopeful that interactomic data will provide more insights, especially for creating targeted treatments that reduce the risk of COVID-19-induced liver damage. For instance, studying the role of proteins involved in programmed cell death could reveal new pathways to treat or prevent HBV from progressing to HCC.
 
Conclusion: A Cautionary Tale for Liver Health Amid COVID-19
The findings from this study underscore the complexity of SARS-CoV-2’s impact on the liver. While most COVID-19 research has focused on respiratory symptoms, this research highlights that other organs, especially the liver, may experience long-term effects. COVID-19’s S1 spike protein affects key liver processes that are involved in chronic conditions like HBV and HCC. This overlap suggests a potential pathway through which the virus could exacerbate liver disease or even lead to cancer.
 
For patients with liver disease, COVID-19 represents a more serious threat, and liver health monitoring is vital. Even those without pre-existing liver issues should be cautious, as COVID-19’s lingering effects may quietly impact liver cells and disrupt normal cellular functions. These findings point to the need for comprehensive care plans that consider the liver’s vulnerability in the aftermath of COVID-19.
 
The study findings were published on a preprint server and are currently being peer reviewed.
https://www.preprints.org/manuscript/202411.0138/v1
 
For the latest COVID-19 News, keep on logging to Thailand Medical News.
 
Read Also:
https://www.thailandmedical.news/news/fatty-liver-disease-increases-risk-of-covid-19-hospitalization-but-majority-do-not-even-know-they-have-fatty-liver-disease
 
https://www.thailandmedical.news/news/breaking-sars-cov-2-infection-induces-increase-of-gp73-that-causes-dysglycaemia-increased-gp73-could-also-imply-future-liver-disease-and-liver-cancer
 
https://www.thailandmedical.news/news/breaking-study-finds-that-upregulated-interleukin-6-drives-development-of-rare-liver-cancers-covid-19-infections-causes-elevated-il-6-levels-in-many
 
https://www.thailandmedical.news/news/new-study-findings-reveal-long-term-risks-of-liver-issues-from-covid-19
 
https://www.thailandmedical.news/news/study-reveals-that-covid-19-is-causing-the-new-onset-of-acute-and-chronic-liver-disease-in-many